Cargando…

Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature

Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context...

Descripción completa

Detalles Bibliográficos
Autores principales: Laugwitz, Lucia, Santhanakumaran, Vidiyaah, Spieker, Mareike, Boehringer, Judith, Bender, Benjamin, Gieselmann, Volkmar, Beck‐Woedl, Stefanie, Bruchelt, Gernot, Harzer, Klaus, Kraegeloh‐Mann, Ingeborg, Groeschel, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259399/
https://www.ncbi.nlm.nih.gov/pubmed/35822086
http://dx.doi.org/10.1002/jmd2.12293
_version_ 1784741771607015424
author Laugwitz, Lucia
Santhanakumaran, Vidiyaah
Spieker, Mareike
Boehringer, Judith
Bender, Benjamin
Gieselmann, Volkmar
Beck‐Woedl, Stefanie
Bruchelt, Gernot
Harzer, Klaus
Kraegeloh‐Mann, Ingeborg
Groeschel, Samuel
author_facet Laugwitz, Lucia
Santhanakumaran, Vidiyaah
Spieker, Mareike
Boehringer, Judith
Bender, Benjamin
Gieselmann, Volkmar
Beck‐Woedl, Stefanie
Bruchelt, Gernot
Harzer, Klaus
Kraegeloh‐Mann, Ingeborg
Groeschel, Samuel
author_sort Laugwitz, Lucia
collection PubMed
description Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context of these genotypes, low ARSA activity has been suggested to lead to an atypical form of MLD or other neurological abnormalities, but data are limited. The aim of our study was to analyse the impact of low ARSA activity in two subjects who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant. Biochemical testing included ARSA activity measurements and urinary sulfatide analysis. Biochemical data of a large cohort of MLD patients, heterozygotes, pseudodeficient individuals and healthy controls were analysed. MRI was performed at 3T using T1‐ and T2‐weighted sequences and MR spectroscopy. We present two long‐term follow‐ups who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant in the ARSA gene in cis. The two related index cases exhibit markedly reduced ARSA activity compared to controls and heterozygous carriers. The neurological evaluation and MRI do not reveal any abnormalities. Our data underline that extremely low enzyme activity due to a pseudodeficiency allele and a disease‐causing variant in the ARSA gene even in cis does not lead to clinical symptoms or pre‐symptomatic MRI changes suspicious for MLD. The review of literature corroborates that any association of low ARSA activity with disease features remains questionable. It seems important to combine the measurement of ARSA activity with elevated sulfatide as well as genetic testing, as done in current newborn screening approaches. Heterozygosity for metachromatic leukodystrophy and an arylsulfatase A pseudodeficiency allele does not cause neurological or neuropsychiatric features.
format Online
Article
Text
id pubmed-9259399
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-92593992022-07-11 Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature Laugwitz, Lucia Santhanakumaran, Vidiyaah Spieker, Mareike Boehringer, Judith Bender, Benjamin Gieselmann, Volkmar Beck‐Woedl, Stefanie Bruchelt, Gernot Harzer, Klaus Kraegeloh‐Mann, Ingeborg Groeschel, Samuel JIMD Rep Case Reports Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disease caused by deficiency of arylsulfatase A (ARSA). Heterozygous carriers of disease‐causing variants and individuals harbouring pseudodeficiency alleles in the ARSA gene exhibit reduced ARSA activity. In the context of these genotypes, low ARSA activity has been suggested to lead to an atypical form of MLD or other neurological abnormalities, but data are limited. The aim of our study was to analyse the impact of low ARSA activity in two subjects who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant. Biochemical testing included ARSA activity measurements and urinary sulfatide analysis. Biochemical data of a large cohort of MLD patients, heterozygotes, pseudodeficient individuals and healthy controls were analysed. MRI was performed at 3T using T1‐ and T2‐weighted sequences and MR spectroscopy. We present two long‐term follow‐ups who are heterozygous for the ARSA pseudodeficiency allele and a disease‐causing variant in the ARSA gene in cis. The two related index cases exhibit markedly reduced ARSA activity compared to controls and heterozygous carriers. The neurological evaluation and MRI do not reveal any abnormalities. Our data underline that extremely low enzyme activity due to a pseudodeficiency allele and a disease‐causing variant in the ARSA gene even in cis does not lead to clinical symptoms or pre‐symptomatic MRI changes suspicious for MLD. The review of literature corroborates that any association of low ARSA activity with disease features remains questionable. It seems important to combine the measurement of ARSA activity with elevated sulfatide as well as genetic testing, as done in current newborn screening approaches. Heterozygosity for metachromatic leukodystrophy and an arylsulfatase A pseudodeficiency allele does not cause neurological or neuropsychiatric features. John Wiley & Sons, Inc. 2022-05-04 /pmc/articles/PMC9259399/ /pubmed/35822086 http://dx.doi.org/10.1002/jmd2.12293 Text en © 2022 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Laugwitz, Lucia
Santhanakumaran, Vidiyaah
Spieker, Mareike
Boehringer, Judith
Bender, Benjamin
Gieselmann, Volkmar
Beck‐Woedl, Stefanie
Bruchelt, Gernot
Harzer, Klaus
Kraegeloh‐Mann, Ingeborg
Groeschel, Samuel
Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title_full Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title_fullStr Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title_full_unstemmed Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title_short Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long‐term follow‐up and review of the literature
title_sort extremely low arylsulfatase a enzyme activity does not necessarily cause symptoms: a long‐term follow‐up and review of the literature
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259399/
https://www.ncbi.nlm.nih.gov/pubmed/35822086
http://dx.doi.org/10.1002/jmd2.12293
work_keys_str_mv AT laugwitzlucia extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT santhanakumaranvidiyaah extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT spiekermareike extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT boehringerjudith extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT benderbenjamin extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT gieselmannvolkmar extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT beckwoedlstefanie extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT brucheltgernot extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT harzerklaus extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT kraegelohmanningeborg extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature
AT groeschelsamuel extremelylowarylsulfataseaenzymeactivitydoesnotnecessarilycausesymptomsalongtermfollowupandreviewoftheliterature